Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • candida utilis
    Junior Member
    • May 2017
    • 6

    #1

    SMART Seq v2: RNA amount and cycles for preampfification

    Hi all,
    We aim to compare differential mRNA expression between 2 different cell types. We sorted 2 populations of cells by FACS, extract RNA by column based methods, and SMARTSEQ v2 for pre-amplificaiton of cDNA.

    Between those cell types, A has very low cell number (150-500 cells). In contrast, B has higher cell number (50,000 cells) but its RNA amount is less. So, I only do RNA quantification for B, because RNA amount in A is too low to be detected by Ribogreen.

    For Pre amplification of cDNA, I have some questions:

    (1) If the starting RNA amount used for SMARTSeq V2 is different between samples, will it affect the RNA Seq results, if we aim to compare the differential mRNA expression between those samples?

    (2) For the pre-amplification of cDNA, will the number of PCR cycles for A and B need to be the same, if I would like to compare the differential mRNA expression between those cell types? If sample A need 20 cycles to get sufficient cDNA, while sample B only need 15 cycles, what should I do? Thank you

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
51 views
0 reactions
Last Post SEQadmin2  
Working...